Blue Star (BLUESTARCO) — Board Meeting

📢 Key Event
Sale of MedTech division to Cyrix Healthcare for up to Rs 40 crores

🔄 What Changed
Divestment of MedTech unit representing 0.33% revenue and 0.21% net worth

🔮 What's Next
Completion targeted by March 31, 2027

💡 Investor Takeaway
This sale generates capital and refocuses the company on core engineering solutions.

Blue Star Limited announced that its wholly owned subsidiary Blue Star Engineering & Electronics executed a Business Transfer Agreement to sell its MedTech division to Cyrix Healthcare Private Limited for up to Rs 40 crores. The slump sale, valued at approximately 0.33% of consolidated revenue and 0.21% of net worth, is expected to close by March 31, 2027 pending regulatory approvals. This strategic divestment allows the company to focus on core engineering solutions while generating significant capital.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLUESTARCO ✨ Ask AI About This

About Blue Star Limited (BLUESTARCO)

Consumer Durables · Consumer Durables · Listed on NSE

Market Cap: ₹30,171.91 Cr P/E: 59.3 ROE: 15.0% ROCE: 18.7% Div Yield: 0.58%

View full BLUESTARCO stock details →

📡 Get AI alerts when BLUESTARCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BLUESTARCO — Free

💡 Ask AI about this filing

"What is the exact consideration structure and payment schedule?" "How will the MedTech sale impact Blue Star's consolidated margins?" "What specific regulatory approvals are required for closing?"

Ask AI Free →

📊 More BLUESTARCO filings

See all BLUESTARCO filings →

🔥 Also filed on 14 August 2026

CEIGALL Ceigall India Limited Financial Results MAHAPEXLTD Maha Rashtra Apex Corporation Limited Corporate Action SAATVIKGL Saatvik Green Energy Limited Financial Results LIBAS Libas Consumer Products Limited Corporate Action GENUSPOWER Genus Power Infrastructures Limited Financial Results LUXIND Lux Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BLUESTARCO files new disclosures

Track BLUESTARCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BLUESTARCO — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd